Protelos® significantly reduces non vertebral fracture risk in postmenopausal women with osteoporosis

The results of the TROPOS (Treatment of Peripheral Osteoporosis) study, published today in the Journal of Clinical Endocrinology and Metabolism show that strontium ranelate (Protelos®) significantly reduces the risk of all non vertebral and, in a high risk group, hip fractures over three years.

Recent Blog Post

Study Reveals Higher BMI Puts Adolescents at Risk for Depression 

5th September 2023 – By King’s College London Children between the ages of 12 and 16 with a higher body...

Diversity at TwinsUK: Genevieve

Genevieve joined the department in 2010 and has since gained an extensive knowledge of the TwinsUK data. She is responsible...

Diversity at TwinsUK: Bridget

Bridget is one of our Clinical Research Nurses, part of the clinic team who you’ll see when coming to St...